CStone Pharmaceuticals (CSPHF)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.145 (16.96%)
At close: Sep 23, 2025
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of $1.29 billion as of October 13, 2025. Its market cap has increased by 415.05% in one year.
Market Cap
1.29B
Enterprise Value
1.25B
Revenue
28.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 1.61B to 1.29B, a decrease of -20.01%. That is a compound annual growth rate of -3.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 1.29B | 241.20% |
| Dec 31, 2024 | 377.98M | 2.10% |
| Dec 29, 2023 | 370.21M | -47.68% |
| Dec 30, 2022 | 707.54M | -42.71% |
| Dec 31, 2021 | 1.23B | -17.43% |
| Dec 31, 2020 | 1.50B | 11.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |